Lycorine

An alkaloid.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Natural product

1
Supporting references
0
Contradictory references
12
AI-suggested references
0
Clinical trials

General information

A bioactive pyrrolidine alkaloid, which has been shown to act also as a non-nucleoside RNA-dependent RNA polymerase inhibitor (Jin et al., 2020).

Lycorine on PubChem
Lycorine on Wikipedia


Synonyms

Amarylline; Galanthidine; Narcissine

 

Structure image - Lycorine

C1CN2CC3=CC4=C(C=C3[C@H]5[C@H]2C1=C[C@@H]([C@H]5O)O)OCO4


Supporting references

Link Tested on Impact factor Notes Publication date
Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections
RdRpol Small molecule In vitro
in silico; Vero cells; SARS-CoV-2 strain βCoV/KOR/KCDC03/2020 4.27

Inhibited SARS-CoV-2 with IC50 of ca. 0.878 μM in vitro. It was predicted to act via SARS-CoV-2 RNA-dependent RNA polymerase (RdRpol) inhibition (based on docking simulations and MERS-CoV RdRpol inhibition in vitro).

Dec/16/2020

AI-suggested references

Link Publication date
Plant-Derived Natural Non-Nucleoside Analog Inhibitors (NNAIs) against RNA-Dependent RNA Polymerase Complex (nsp7/nsp8/nsp12) of SARS-CoV-2.
Dec/01/2021
In a search for potential drug candidates for combating COVID-19: computational study revealed salvianolic acid B as a potential therapeutic targeting 3CLpro and spike proteins.
Apr/04/2020
Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture
May/21/2020
A computational approach for the screening of potential antiviral compounds against SARS-CoV-2 protease: Ionic liquid vs herbal and natural compounds.
Jan/07/2021
A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors
Feb/03/2021
In silico approach for identification of natural compounds as potential COVID 19 main protease (Mpro) inhibitors.
Jun/20/2021
SARS-CoV-2 RdRp Inhibitors Selected from a Cell-Based SARS-CoV-2 RdRp Activity Assay System.
Aug/11/2021
Screening for natural and derived bio-active compounds in preclinical and clinical studies: One of the frontlines of fighting the coronaviruses pandemic.
Aug/29/2020
Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19).
Sep/25/2020
Natural product-derived phytochemicals as potential agents against coronaviruses: A review
Apr/30/2020
Phytogenic Products and Phytochemicals as a Candidate Strategy to Improve Tolerance to Coronavirus
Oct/20/2020
Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay
Feb/25/2022